Error: Could not add to watchlist. X

OncoMed Pharmaceuticals Inc

+ Watchlist
OMED:US
NASDAQ GS
19.59
USD
0.75
3.69%
As of 17:20:00 ET on 08/31/2015.
Open
20.13
Day Range
19.40 - 20.53
Volume
105,638
Previous Close
20.34
52Wk Range
16.63 - 29.83
1 Yr Return
-3.45%
Open
20.13
Day Range
19.40 - 20.53
Volume
105,638
Previous Close
20.34
52Wk Range
16.63 - 29.83
1 Yr Return
-3.45%
YTD Return
-9.97%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.89
Market Cap (m USD)
588.913
Shares Outstanding (m)
30.062
Price/Sales (TTM)
13.95
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
OncoMed Pharmaceuticals, Inc. provides biotechnology research and development. The Company synthesizes oncogenic mutations in stem cells that allows the cells to grow without normal limitations in attempts to exploit therapies that selectively target tumor initiating cells. OncoMed Pharmaceuticals serves the healthcare industry and cancer therapy patients in the United States.
ADDRESS
800 Chesapeake Drive
Redwood City, CA 94063
United States
PHONE
1-650-995-8200
  • Paul J Hastings
    President/CEO
  • John A Lewicki
    Exec VP/Chief Scientific Ofcr
  • Jakob Dupont
    Senior VP/Chief Medical Ofcr
  • Sunil Patel
    Senior VP:Finance/CFO
  • Austin Gurney
    Senior VP:Molecular & Cellular
Show More